Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome

Table 3

lnc-DC alone or lnc-DC combined with anti-SSA and anti-SSB for the discriminative ability of pSS patients from HC and other autoimmune disease such as SLE and RA.

Characteristic	AUC	SE	P value	95% CI	Sensitivity	Specificity
lnc-DC+antu-SSA+anti-SSB of pSS	0.84	0.03	<0.001	0.79~0.89	78.50	89.91
lnc-DC of pSS	0.80	0.03	<0.001	0.75~0.86	75.42	84.50
Anti-SSA of pSS	0.74	0.05	<0.001	0.68~0.81	72.31	62.39
Anti-SSB of pSS	0.70	0.05	<0.01	0.63~0.77	71.53	64.22
lnc-DC of RA	0.54	0.06	0.464	0.44~0.64	50.00	56.88
lnc-DC of SLE	0.51	0.06	0.836	0.41~0.61	64.09	40.37